Seroconversion and neutralizing antibodies production after completion of Pfizer-BioNTech BNT 162b2 vaccination scheme among psoriatic patients receiving biological or topical treatment: a prospective observational cohort study.
Giuseppe StincoEnzo ErrichettiMatteo FiginiAlba GuglielmoBenedetta FazziLuca QuartuccioAlen ZabottiSalvatore De VitaMiriam IsolaMaria De MartinoSilvia RossiRiccardo LucisMartina FabrisAntonio Paolo BeltramiFrancesco CurcioFederica D'AurizioPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)